Synthon Pharmaceuticals, Inc.
Records under this name other than patents Synthon Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Synthon Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,776,358 | Extended release venlafaxine besylate tablets Formerly held In force (reinstated) · USPTO record | In force (reinstated) | USPTO record | |
| US 7,018,658 | Pharmaceutical pellets comprising tamsulosin Term ended Term ended Nov 29, 2023 · USPTO record | Term ended | Term ended Nov 29, 2023 | USPTO record |
| US 6,717,015 | Venlafaxine besylate Formerly held Term ended Term ended Mar 27, 2023 · USPTO record | Term ended | Term ended Mar 27, 2023 | USPTO record |
| US 7,598,271 | Crystalline paroxetine methane sulfonate Formerly held Term ended Term ended Feb 11, 2023 · USPTO record | Term ended | Term ended Feb 11, 2023 | USPTO record |
| US 6,645,523 | Paroxetine Compositions and Processes for Making the Same Formerly held Term ended Term ended Aug 28, 2021 · High confidence | Term ended | Term ended Aug 28, 2021 | High confidence |
| US 6,900,327 | 4-Phenylpiperidine Compounds Formerly held Term ended Ended no later than Jun 10, 2017 · Low confidence | Term ended | Ended no later than Jun 10, 2017 | Low confidence |
| US 7,829,716 | Process for making montelukast and intermediates therefor Lapsed on the fee record Ended Nov 9, 2014 · USPTO record | Lapsed on the fee record | Ended Nov 9, 2014 | USPTO record |
| US 5,874,447 | 4-Phenylpiperidine compounds for treating depression Formerly held Term ended Term ended no later than Feb 23, 2019 · Low confidence | Term ended | Term ended no later than Feb 23, 2019 | Low confidence |